The Value of Genomic Analysis of Breast Cancer in Drug Development
Szekely B, Pusztai L. The Value of Genomic Analysis of Breast Cancer in Drug Development. JNCI Monographs 2011, 2011: 60-62. PMID: 22043042, DOI: 10.1093/jncimonographs/lgr039.Peer-Reviewed Original ResearchConceptsRational combination treatment strategiesCombination treatment strategiesTreatment strategiesBreast cancerTherapeutic targetResponse markersNew drugsSuccess rateDrug developmentCancerHigh-throughput genomic analysis